Sign In
Buy CHRS
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
Is Coherus BioSciences a Buy?
04:53pm, Tuesday, 26'th May 2020
The biosimilar leader has found quick success with its first major drug product, but the stock's performance hasn't seemed to reflect that.
3 Stocks Trading at Attractive Valuations
04:47pm, Thursday, 21'st May 2020
These strong businesses could have high potential Continue reading...
Coherus Is a ‘Top Pick’ for COVID-19 Environment, Says Top Analyst
11:08pm, Wednesday, 13'th May 2020
Many biotechs have been on hot streaks in 2020, particularly those with the coronavirus on their agenda, as valuations have shot up on the back of urgently needed solutions for COVID-19. But the trend
Edited Transcript of CHRS earnings conference call or presentation 7-May-20 8:30pm GMT
07:56pm, Monday, 11'th May 2020
Q1 2020 Coherus BioSciences Inc Earnings Call
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
06:02pm, Monday, 11'th May 2020
Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
Were Hedge Funds Right About Coherus Biosciences Inc (CHRS)?
02:47am, Monday, 11'th May 2020
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds. One thing they don't realize is that 100% of the passive funds didn't see the c
Investors in Coherus BioSciences, Inc. (NASDAQ:CHRS) had a good week, as its shares rose 7.9% to close at US$17.30...
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q1 2020 Results - Earnings Call Transcript
07:29pm, Saturday, 09'th May 2020
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q1 2020 Results Earnings Conference Call May 07, 2020, 04:30 PM ET Company Participants David Arrington - VP of IR &
Edited Transcript of CHRS earnings conference call or presentation 7-May-20 8:30pm GMT
11:33pm, Friday, 08'th May 2020
Q1 2020 Coherus BioSciences Inc Earnings Call
Coherus BioSciences Inc (CHRS) Q1 2020 Earnings Call Transcript
09:30pm, Friday, 08'th May 2020
Ladies and gentlemen, thank you for standing by and welcome to the Coherus BioSciences 2020 First Quarter Earnings Conference Call. This release can be found on the Coherus BioSciences website. Join
Those Who Purchased Coherus BioSciences (NASDAQ:CHRS) Shares Five Years Ago Have A 31% Loss To Show For It
05:05pm, Friday, 08'th May 2020
Ideally, your overall portfolio should beat the market average. But even the best stock picker will only win with some...
Coherus BioSciences Q1 EPS $0.480 Misses $0.560 Estimate, Sales $116.180M Miss $119.520M Estimate
09:07pm, Thursday, 07'th May 2020Coherus BioSciences Reports First Quarter 2020 Financial Results
08:08pm, Thursday, 07'th May 2020
– First Quarter UDENYCA® Net Sales of $116.2 Million ––Net Income of $35.6 Million –– Non-GAAP Net Income of $49.8 Million – REDWOOD CITY, Calif., May 07, 2020 -- Coherus.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
